These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 19075645
1. New inhibitors of glycogen phosphorylase as potential antidiabetic agents. Somsák L, Czifrák K, Tóth M, Bokor E, Chrysina ED, Alexacou KM, Hayes JM, Tiraidis C, Lazoura E, Leonidas DD, Zographos SE, Oikonomakos NG. Curr Med Chem; 2008; 15(28):2933-83. PubMed ID: 19075645 [Abstract] [Full Text] [Related]
3. Computation as a tool for glycogen phosphorylase inhibitor design. Hayes JM, Leonidas DD. Mini Rev Med Chem; 2010 Oct; 10(12):1156-74. PubMed ID: 20716053 [Abstract] [Full Text] [Related]
4. Recent advances in the allosteric inhibition of glycogen phosphorylase. Loughlin WA. Mini Rev Med Chem; 2010 Oct; 10(12):1139-55. PubMed ID: 20716052 [Abstract] [Full Text] [Related]
5. Glycogen phosphorylase as a molecular target for type 2 diabetes therapy. Oikonomakos NG. Curr Protein Pept Sci; 2002 Dec; 3(6):561-86. PubMed ID: 12470212 [Abstract] [Full Text] [Related]
6. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Rath VL, Ammirati M, Danley DE, Ekstrom JL, Gibbs EM, Hynes TR, Mathiowetz AM, McPherson RK, Olson TV, Treadway JL, Hoover DJ. Chem Biol; 2000 Sep; 7(9):677-82. PubMed ID: 10980448 [Abstract] [Full Text] [Related]
7. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site. Kristiansen M, Andersen B, Iversen LF, Westergaard N. J Med Chem; 2004 Jul 01; 47(14):3537-45. PubMed ID: 15214781 [Abstract] [Full Text] [Related]
8. The prototype of glycogen phosphorylase. Chrysina ED. Mini Rev Med Chem; 2010 Oct 01; 10(12):1093-101. PubMed ID: 20716055 [Abstract] [Full Text] [Related]
13. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Chen L, Li H, Liu J, Zhang L, Liu H, Jiang H. Bioorg Med Chem; 2007 Nov 01; 15(21):6763-74. PubMed ID: 17719791 [Abstract] [Full Text] [Related]
14. High Consistency of Structure-Based Design and X-Ray Crystallography: Design, Synthesis, Kinetic Evaluation and Crystallographic Binding Mode Determination of Biphenyl-N-acyl-β-d-Glucopyranosylamines as Glycogen Phosphorylase Inhibitors. Fischer T, Koulas SM, Tsagkarakou AS, Kyriakis E, Stravodimos GA, Skamnaki VT, Liggri PGV, Zographos SE, Riedl R, Leonidas DD. Molecules; 2019 Apr 03; 24(7):. PubMed ID: 30987252 [Abstract] [Full Text] [Related]
15. Modeling aided design of potent glycogen phosphorylase inhibitors. Deng Q, Lu Z, Bohn J, Ellsworth KP, Myers RW, Geissler WM, Harris G, Willoughby CA, Chapman K, McKeever B, Mosley R. J Mol Graph Model; 2005 Apr 03; 23(5):457-64. PubMed ID: 15781188 [Abstract] [Full Text] [Related]
16. Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes. Leonidas DD, Hayes JM, Kato A, Skamnaki VT, Chatzileontiadou DS, Kantsadi AL, Kyriakis E, Chetter BA, Stravodimos GA. Curr Med Chem; 2017 Apr 03; 24(4):384-403. PubMed ID: 27855623 [Abstract] [Full Text] [Related]
17. A new class of glycogen phosphorylase inhibitors. Lu Z, Bohn J, Bergeron R, Deng Q, Ellsworth KP, Geissler WM, Harris G, McCann PE, McKeever B, Myers RW, Saperstein R, Willoughby CA, Yao J, Chapman K. Bioorg Med Chem Lett; 2003 Nov 17; 13(22):4125-8. PubMed ID: 14592521 [Abstract] [Full Text] [Related]
18. Glycogen phosphorylase inhibitors: a patent review (2013 - 2015). Donnier-Maréchal M, Vidal S. Expert Opin Ther Pat; 2016 Nov 17; 26(2):199-212. PubMed ID: 26666989 [Abstract] [Full Text] [Related]